Atlas Trials

Drug-Drug Interaction (DDI)

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Drug-Drug Interaction (DDI)

RecordFirmDate
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors (NCT05176483)Exelixis2021-12-14
Drug-Drug Interaction (DDI) Study for TD-9855 (NCT03432793)Theravance Biopharma2018-02-28
Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects (NCT02169713)Astellas Pharma Europe B.V.2014-05-01
Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects (NCT02127034)Astellas Pharma Europe B.V.2014-03-01
A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men (NCT02138799)Astellas Pharma Europe B.V.2013-07-01
A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects (NCT02083627)Astellas Pharma Europe B.V.2013-02-01
A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects (NCT01797198)Astellas Pharma Europe B.V.2012-04-01

Track Drug-Drug Interaction (DDI) automatically

Every clearance here is in the API, with alerts when new ones post.